Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (71-80 of 308) with videos related to

Pageof 31
Sort By:
American Journal of Pharmaceutical Education|April 3, 2018
A Longitudinal Approach to Changes in the Motivation of Dutch Pharmacists in the Current Continuing Education SystemSharon L Tjin A Tsoi, Anthonius de Boer, Gerda Croiset, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Pharmacogenetics of glucose-lowering drug treatment: a systematic reviewOzlem Bozkurt, Anthonius de Boer, Diederick E Grobbee, et al.
Trials|March 9, 2017
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic reviewTurki A Althunian, Anthonius de Boer, Olaf H Klungel, et al.
Orphanet Journal of Rare Diseases|August 6, 2014
The influence of the European paediatric regulation on marketing authorisation of orphan drugs for childrenAnnemarie Rosan Kreeftmeijer-Vegter, Anthonius de Boer, Roselinda H van der Vlugt-Meijer, et al.
Journal of the American Geriatrics Society|October 25, 2019
Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink DatabaseGeert J Lefeber, Huiberdina L Koek, Patrick C Souverein, et al.
Journal of General Internal Medicine|August 21, 2009
Systematic review of pharmacogenetic warfarin dosingRianne M F van Schie, Andrea L Jorgensen, Anthonius de Boer, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Clinical and economic consequences of pharmacogenetic-guided dosing of warfarinTalitha I Verhoef, Tom Schalekamp, William K Redekop, et al.
Stroke|February 10, 2021
Statins After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research Datalink DatabaseGeert J Lefeber, Wilma Knol, Patrick C Souverein, et al.
Drug Discovery Today|September 16, 2024
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approachesAmos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
Pharmacoepidemiology and Drug Safety|April 18, 2023
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19Mirjam Hempenius, Sophie H Bots, Rolf H H Groenwold, et al.
Pageof 31

Showing results (71-80 of 308) with videos related to

Sort By:
Pageof 31
American Journal of Pharmaceutical Education|April 3, 2018
A Longitudinal Approach to Changes in the Motivation of Dutch Pharmacists in the Current Continuing Education SystemSharon L Tjin A Tsoi, Anthonius de Boer, Gerda Croiset, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Pharmacogenetics of glucose-lowering drug treatment: a systematic reviewOzlem Bozkurt, Anthonius de Boer, Diederick E Grobbee, et al.
Trials|March 9, 2017
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic reviewTurki A Althunian, Anthonius de Boer, Olaf H Klungel, et al.
Orphanet Journal of Rare Diseases|August 6, 2014
The influence of the European paediatric regulation on marketing authorisation of orphan drugs for childrenAnnemarie Rosan Kreeftmeijer-Vegter, Anthonius de Boer, Roselinda H van der Vlugt-Meijer, et al.
Journal of the American Geriatrics Society|October 25, 2019
Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink DatabaseGeert J Lefeber, Huiberdina L Koek, Patrick C Souverein, et al.
Journal of General Internal Medicine|August 21, 2009
Systematic review of pharmacogenetic warfarin dosingRianne M F van Schie, Andrea L Jorgensen, Anthonius de Boer, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Clinical and economic consequences of pharmacogenetic-guided dosing of warfarinTalitha I Verhoef, Tom Schalekamp, William K Redekop, et al.
Stroke|February 10, 2021
Statins After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research Datalink DatabaseGeert J Lefeber, Wilma Knol, Patrick C Souverein, et al.
Drug Discovery Today|September 16, 2024
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approachesAmos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
Pharmacoepidemiology and Drug Safety|April 18, 2023
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19Mirjam Hempenius, Sophie H Bots, Rolf H H Groenwold, et al.
Pageof 31